Showing results (1501-1510 of 1,518) with videos related to
Sort By:
Pageof 152
European Journal of Cancer (Oxford, England : 1990)|May 22, 2022
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertionsPetros Christopoulos, Klaus Kluck, Martina Kirchner, et al.Bioorganic & Medicinal Chemistry Letters|January 17, 2018
Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228Folkert Reck, Alun Bermingham, Johanne Blais, et al.Clinical & Experimental Metastasis|July 23, 2025
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, et al.JAMA Dermatology|January 18, 2023
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and EuropeMargo J Reeder, Erin Warshaw, Srikanth Aravamuthan, et al.Journal of Experimental & Clinical Cancer Research : CR|April 29, 2025
Red blood cell-tumor cell interactions promote tumor cell progressionThais Pereira-Veiga, Celso Yáñez-Gómez, Aleksi Pekkarinen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 13, 2019
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical TrialSebastian Michels, Bartomeu Massutí, Hans-Ulrich Schildhaus, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 TrialLuis G Paz-Ares, Suresh S Ramalingam, Tudor-Eliade Ciuleanu, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2025
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of lifeHenriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, et al.ESMO Open|September 4, 2021
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerG Mountzios, E Samantas, K Senghas, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 12, 2023
Early Detection of Lung Cancer Using Small RNAsTobias Sikosek, Rastislav Horos, Franziska Trudzinski, et al.Pageof 152